EGF103659
Laufzeit: 01.01.2007 - 31.12.2008
imported
Kurzfassung
An Open-Label Expanded Access Study of Lapatinib and
Capecitabine Therapy in Subjects with ErbB2 Overexpressing
Locally Advanced or Metastatic Breast Cancer
Laufzeit: 01.01.2007 - 31.12.2008
An Open-Label Expanded Access Study of Lapatinib and
Capecitabine Therapy in Subjects with ErbB2 Overexpressing
Locally Advanced or Metastatic Breast Cancer